Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octaplex dose comparison in vitamin K antagonist-related intracranial haemorrhage
ISRCTN34868002Phase 3Completed
- Sponsor
- Octapharma
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of coagulation factor X human and phytomenadione in intracerebral hemorrhage (ICH) (2 arms), sponsored by Octapharma. Primary endpoint: INR shortly after infusion. Started Sep 2008; status: completed.
02
Drugs
coagulation factor X humanphytomenadione
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN34868002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34868002.